marketcaparena
Search

    NOVT

    NOVANTA INC

    Company overview

    Market capitalization
    —
    Employees
    3,000
    Latest publication
    2026-09-29
    About NOVANTA INC

    Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-07-03 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue265,807,000USD257,707,000USD258,349,000USD247,836,000USD241,049,000USD233,366,000USD238,060,000USD244,405,000USD
    Cost Of Revenue144,892,000USD149,903,000USD153,210,000USD143,843,000USD141,174,000USD134,566,000USD129,835,000USD135,190,000USD
    Gross Profit120,915,000USD107,804,000USD105,139,000USD103,993,000USD99,875,000USD98,800,000USD108,225,000USD109,215,000USD
    Research Development23,968,000USD23,251,000USD22,867,000USD24,090,000USD25,289,000USD23,238,000USD25,285,000USD23,253,000USD
    Selling General Administrative59,972,000USD54,409,000USD51,582,000USD51,378,000USD47,103,000USD45,596,000USD43,301,000USD44,319,000USD
    Total Operating Expenses102,854,000USD77,660,000USD74,449,000USD75,468,000USD72,392,000USD68,834,000USD81,518,000USD76,660,000USD
    Operating Income18,061,000USD30,144,000USD30,690,000USD28,525,000USD27,483,000USD29,966,000USD26,707,000USD32,555,000USD
    Total Other Income Expense Net-2,163,000USD-3,790,000USD-9,013,000USD-12,767,000USD-21,694,000USD-3,548,000USD-5,912,000USD-8,330,000USD
    Income Before Tax15,898,000USD26,354,000USD21,677,000USD15,758,000USD5,789,000USD26,418,000USD20,795,000USD24,225,000USD
    Income Tax Expense3,357,000USD5,255,000USD4,206,000USD5,105,000USD1,292,000USD5,210,000USD4,331,000USD5,033,000USD
    Net Income12,541,000USD21,099,000USD17,471,000USD10,653,000USD4,497,000USD21,208,000USD16,464,000USD19,192,000USD
    Interest Expense—1,843,000USD3,999,000USD6,014,000USD5,815,000USD5,644,000USD6,890,000USD8,079,000USD
    Net Interest Income—-1,843,000USD-3,999,000USD-6,014,000USD-5,815,000USD-5,644,000USD-6,890,000USD-8,079,000USD
    Tax Provision—5,255,000USD4,206,000USD5,105,000USD1,292,000USD5,210,000USD4,331,000USD5,033,000USD
    Net Income From Continuing Ops—21,099,000USD17,471,000USD10,653,000USD4,497,000USD21,208,000USD16,464,000USD19,192,000USD
    Ebit—28,197,000USD25,676,000USD21,772,000USD11,604,000USD32,062,000USD33,091,000USD35,054,000USD
    Ebitda—42,357,000USD42,753,000USD37,483,000USD27,185,000USD45,625,000USD47,454,000USD49,209,000USD
    Depreciation And Amortization—14,160,000USD17,077,000USD15,711,000USD15,581,000USD13,563,000USD14,363,000USD14,155,000USD
    Reconciled Depreciation—14,160,000USD17,077,000USD15,711,000USD15,581,000USD13,563,000USD14,363,000USD14,155,000USD
    Unclassified Operating Expenses——————12,932,000USD9,088,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20162016-12-31 · USD
    Total Revenue980,600,000USD949,245,000USD881,662,000USD860,903,000USD706,793,000USD590,623,000USD626,099,000USD384,758,000USD
    Cost Of Revenue572,793,000USD527,700,000USD481,765,000USD482,431,000USD406,465,000USD346,106,000USD364,014,000USD222,306,000USD
    Gross Profit407,807,000USD421,545,000USD399,897,000USD378,472,000USD300,328,000USD244,517,000USD262,085,000USD162,452,000USD
    Research Development95,484,000USD95,515,000USD91,682,000USD85,770,000USD72,522,000USD60,996,000USD55,965,000USD32,002,000USD
    Selling General Administrative195,659,000USD175,943,000USD161,468,000USD158,901,000USD129,155,000USD109,853,000USD118,407,000USD81,691,000USD
    Total Operating Expenses291,143,000USD310,961,000USD289,401,000USD275,393,000USD236,274,000USD188,629,000USD206,803,000USD129,497,000USD
    Operating Income116,664,000USD110,584,000USD110,496,000USD103,079,000USD64,054,000USD55,888,000USD55,282,000USD32,955,000USD
    Interest Expense21,472,000USD31,489,000USD25,818,000USD15,616,000USD7,387,000USD6,564,000USD8,493,000USD4,559,000USD
    Net Interest Income-21,472,000USD-31,489,000USD-25,586,000USD-15,616,000USD-7,387,000USD-6,564,000USD-8,493,000USD-4,559,000USD
    Income Before Tax69,642,000USD79,066,000USD83,748,000USD87,159,000USD56,172,000USD48,403,000USD45,766,000USD32,522,000USD
    Income Tax Expense15,813,000USD14,979,000USD10,870,000USD13,108,000USD5,841,000USD3,882,000USD4,993,000USD10,519,000USD
    Tax Provision15,813,000USD14,979,000USD11,308,000USD13,108,000USD5,841,000USD3,882,000USD4,993,000USD10,519,000USD
    Net Income53,829,000USD64,087,000USD72,878,000USD74,051,000USD50,331,000USD44,521,000USD40,773,000USD22,003,000USD
    Net Income From Continuing Ops53,829,000USD64,087,000USD75,629,000USD74,051,000USD50,331,000USD44,521,000USD40,773,000USD22,003,000USD
    Ebit91,114,000USD124,293,000USD123,310,000USD107,463,000USD82,074,000USD59,698,000USD71,856,000USD41,073,000USD
    Ebitda153,046,000USD179,856,000USD169,922,000USD160,621,000USD125,468,000USD97,991,000USD110,136,000USD61,430,000USD
    Depreciation And Amortization61,932,000USD55,563,000USD46,612,000USD53,158,000USD43,394,000USD38,293,000USD38,280,000USD20,357,000USD
    Reconciled Depreciation61,932,000USD55,563,000USD47,224,000USD53,158,000USD43,394,000USD38,293,000USD38,280,000USD—
    Total Other Income Expense Net-47,022,000USD-31,518,000USD-26,748,000USD-15,920,000USD-7,882,000USD-7,485,000USD-9,516,000USD-433,000USD
    Unclassified Operating Expenses—39,503,000USD36,251,000USD30,722,000USD34,597,000USD17,780,000USD32,431,000USD15,804,000USD
    Non Operating Income Net Other———-304,000USD-495,000USD-921,000USD-1,023,000USD4,518,000USD
    Net Income Applicable To Common Shares———74,051,000USD50,331,000USD44,521,000USD40,773,000USD22,003,000USD
    Minority Interest—————0USD0USD46,923,000USD
    Interest Income——————9,273,000USD2,242,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-07-03 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets2,139,565,000USD1,799,055,000USD1,807,106,000USD1,505,811,000USD1,511,069,000USD1,385,456,000USD1,388,511,000USD1,418,823,000USD
    Cash And Equivalents718,650,000USD———————
    Total Current Assets1,123,537,000USD786,803,000USD782,601,000USD468,419,000USD462,100,000USD434,138,000USD433,648,000USD436,934,000USD
    Other Current Assets20,633,000USD30,927,000USD28,566,000USD28,658,000USD22,921,000USD18,457,000USD24,027,000USD25,721,000USD
    Other Non Current Assets15,578,000USD———————
    Total Liabilities523,107,000USD———————
    Total Current Liabilities245,882,000USD220,792,000USD212,367,000USD186,860,000USD181,938,000USD169,590,000USD167,791,000USD156,600,000USD
    Other Current Liabilities18,835,000USD———————
    Other Non Current Liabilities24,487,000USD———————
    Total Stockholder Equity1,616,458,000USD1,311,028,000USD1,314,287,000USD801,476,000USD801,446,000USD769,755,000USD745,698,000USD742,195,000USD
    Total Equity Including Noncontrolling Interest1,616,458,000USD———————
    Short Long Term Debt82,998,000USD40,416,000USD38,291,000USD5,685,000USD5,203,000USD4,852,000USD4,691,000USD5,016,000USD
    Long Term Debt188,157,000USD201,005,000USD212,538,000USD445,658,000USD454,037,000USD385,279,000USD411,949,000USD452,502,000USD
    Deferred Revenue29,517,000USD———————
    Deferred Revenue Non Current18,448,000USD———————
    Net Receivables178,748,000USD173,934,000USD184,880,000USD170,563,000USD161,202,000USD164,201,000USD151,026,000USD164,502,000USD
    Inventory192,709,000USD193,143,000USD188,284,000USD179,977,000USD168,065,000USD145,435,000USD144,606,000USD154,021,000USD
    Property Plant Equipment Net166,530,000USD157,322,000USD160,188,000USD163,056,000USD162,983,000USD153,835,000USD156,043,000USD164,241,000USD
    Goodwill642,365,000USD———————
    Intangible Assets159,831,000USD170,299,000USD180,776,000USD193,248,000USD203,630,000USD177,724,000USD185,844,000USD198,394,000USD
    Accounts Payable97,480,000USD96,203,000USD94,865,000USD100,210,000USD88,973,000USD82,513,000USD76,890,000USD68,720,000USD
    Short Term Debt9,876,000USD50,107,000USD48,976,000USD16,654,000USD15,505,000USD15,580,000USD15,329,000USD15,746,000USD
    Common Stock423,856,000USD423,856,000USD423,856,000USD423,856,000USD423,856,000USD423,856,000USD423,856,000USD423,856,000USD
    Retained Earnings355,018,000USD342,477,000USD321,378,000USD303,907,000USD293,254,000USD288,757,000USD267,549,000USD251,085,000USD
    Accumulated Other Comprehensive Income-10,850,000USD-11,718,000USD-3,004,000USD-2,786,000USD-1,132,000USD-21,346,000USD-29,921,000USD-12,674,000USD
    Total Liab—488,027,000USD492,819,000USD704,335,000USD709,623,000USD615,701,000USD642,813,000USD676,628,000USD
    Other Current Liab—58,204,000USD68,526,000USD57,959,000USD57,617,000USD47,347,000USD53,857,000USD48,378,000USD
    Capital Stock—423,856,000USD423,856,000USD423,856,000USD423,856,000USD423,856,000USD423,856,000USD423,856,000USD
    Good Will—643,379,000USD647,348,000USD647,513,000USD649,093,000USD589,054,000USD584,098,000USD594,088,000USD
    Cash—388,799,000USD380,871,000USD89,221,000USD109,912,000USD106,045,000USD113,989,000USD92,690,000USD
    Cash And Short Term Investments—388,799,000USD380,871,000USD89,221,000USD109,912,000USD106,045,000USD113,989,000USD92,690,000USD
    Current Deferred Revenue—16,278,000USD—8,029,999USD6,906,000USD8,173,000USD5,715,000USD8,342,000USD
    Net Debt—-98,313,000USD-39,263,000USD416,063,000USD403,495,000USD336,486,000USD357,012,000USD421,599,000USD
    Short Long Term Debt Total—290,486,000USD341,608,000USD505,284,000USD513,407,000USD442,531,000USD471,001,000USD514,289,000USD
    Property Plant Equipment Gross—157,322,000USD292,748,000USD163,056,000USD162,983,000USD153,835,000USD267,819,000USD164,241,000USD
    Common Stock Shares Outstanding—41,158,000shares38,681,000shares36,040,000shares36,076,000shares36,130,000shares36,148,000shares36,129,000shares
    Non Current Assets Total—1,012,252,000USD1,024,505,000USD1,037,392,000USD1,048,969,000USD951,318,000USD954,863,000USD981,889,000USD
    Non Current Liabilities Total—267,235,000USD280,452,000USD517,475,000USD527,685,000USD446,111,000USD475,022,000USD520,028,000USD
    Non Current Liabilities Other—5,181,000USD4,638,000USD3,921,000USD4,036,000USD1,279,000USD1,316,000USD1,508,000USD
    Non Currrent Assets Other—11,587,000USD8,812,000USD6,487,000USD6,283,000USD5,701,000USD5,991,000USD5,927,000USD
    Net Working Capital—566,011,000USD570,234,000USD281,559,000USD280,162,000USD264,548,000USD265,857,000USD280,334,000USD
    Unclassified Non Current Assets—29,665,000USD27,381,000USD27,088,000USD26,980,000USD25,004,000USD22,887,000USD19,239,000USD
    Unclassified Current Liabilities—-40,416,000USD-38,291,000USD—7,734,000USD11,125,000USD11,309,000USD10,398,000USD
    Unclassified Non Current Liabilities—61,049,000USD63,276,000USD67,896,000USD69,612,000USD59,553,000USD61,757,000USD66,018,000USD
    Unclassified Equity—132,557,000USD148,201,000USD-347,357,000USD-338,388,000USD-345,368,000USD-339,642,000USD-343,928,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets1,807,106,000USD1,388,511,000USD1,226,056,000USD1,241,212,000USD1,227,883,000USD865,179,000USD869,736,000USD719,576,000USD
    Intangible Assets180,776,000USD185,844,000USD145,022,000USD175,766,000USD220,989,000USD148,521,000USD166,175,000USD142,920,000USD
    Other Current Assets28,566,000USD24,027,000USD21,465,000USD14,720,000USD15,158,000USD11,328,000USD17,872,000USD11,007,000USD
    Total Liab492,819,000USD642,813,000USD552,596,000USD663,626,000USD706,592,000USD388,370,000USD452,564,000USD351,321,000USD
    Total Stockholder Equity1,314,287,000USD745,698,000USD673,460,000USD577,586,000USD521,291,000USD476,809,000USD417,172,000USD368,255,000USD
    Other Current Liab62,670,000USD53,857,000USD54,785,000USD54,248,000USD90,885,000USD37,887,000USD67,107,000USD42,130,000USD
    Common Stock423,856,000USD423,856,000USD423,856,000USD423,856,000USD423,856,000USD423,856,000USD423,856,000USD423,856,000USD
    Capital Stock423,856,000USD423,856,000USD423,856,000USD423,856,000USD423,856,000USD423,856,000USD423,856,000USD423,856,000USD
    Retained Earnings321,378,000USD267,549,000USD203,462,000USD130,584,000USD56,533,000USD6,202,000USD-38,319,000USD-79,092,000USD
    Good Will647,348,000USD584,098,000USD484,507,000USD478,897,000USD479,500,000USD285,980,000USD274,710,000USD217,662,000USD
    Cash380,871,000USD113,989,000USD105,051,000USD100,105,000USD117,393,000USD125,054,000USD78,944,000USD82,043,000USD
    Cash And Short Term Investments380,871,000USD113,989,000USD105,051,000USD100,105,000USD117,393,000USD125,054,000USD78,944,000USD82,043,000USD
    Total Current Assets782,601,000USD433,648,000USD415,297,000USD420,519,000USD373,825,000USD304,173,000USD304,512,000USD281,769,000USD
    Total Current Liabilities212,367,000USD167,791,000USD139,175,000USD164,522,000USD183,938,000USD114,229,000USD134,846,000USD104,196,000USD
    Net Debt-39,263,000USD357,012,000USD299,507,000USD389,278,000USD376,007,000USD129,999,000USD196,724,000USD125,335,000USD
    Short Term Debt48,976,000USD15,329,000USD13,875,000USD13,261,000USD13,030,000USD21,416,000USD10,074,000USD4,535,000USD
    Short Long Term Debt38,291,000USD4,691,000USD4,968,000USD4,800,000USD5,097,000USD5,508,000USD5,031,000USD4,535,000USD
    Short Long Term Debt Total341,608,000USD471,001,000USD404,558,000USD489,383,000USD493,400,000USD255,053,000USD275,668,000USD207,378,000USD
    Long Term Debt212,538,000USD411,949,000USD349,404,000USD430,662,000USD429,361,000USD194,927,000USD215,334,000USD202,843,000USD
    Net Receivables184,880,000USD151,026,000USD139,410,000USD137,697,000USD115,617,000USD75,054,000USD91,078,000USD83,955,000USD
    Inventory188,284,000USD144,606,000USD149,371,000USD167,997,000USD125,657,000USD92,737,000USD116,618,000USD104,764,000USD
    Accounts Payable94,865,000USD76,890,000USD57,195,000USD75,225,000USD68,514,000USD42,966,000USD52,585,000USD50,733,000USD
    Property Plant Equipment Net160,188,000USD156,043,000USD147,751,000USD146,503,000USD135,777,000USD113,120,000USD112,736,000USD65,464,000USD
    Property Plant Equipment Gross292,748,000USD267,819,000USD250,809,000USD146,503,000USD135,777,000USD113,120,000USD112,736,000USD65,464,000USD
    Accumulated Other Comprehensive Income-3,004,000USD-29,921,000USD-24,038,000USD-32,009,000USD-12,866,000USD-12,241,000USD-18,113,000USD-22,527,000USD
    Common Stock Shares Outstanding36,702,000shares36,124,000shares36,031,000shares35,909,000shares35,781,000shares35,654,000shares35,546,000shares35,473,000shares
    Non Current Assets Total1,024,505,000USD954,863,000USD810,759,000USD820,693,000USD854,058,000USD561,006,000USD565,224,000USD437,807,000USD
    Non Current Liabilities Total280,452,000USD475,022,000USD413,421,000USD499,104,000USD522,654,000USD274,141,000USD317,718,000USD247,125,000USD
    Non Current Liabilities Other4,638,000USD1,316,000USD1,687,000USD51,248,000USD59,555,000USD55,080,000USD75,708,000USD21,650,000USD
    Non Currrent Assets Other8,812,000USD5,991,000USD5,617,000USD4,414,000USD5,586,000USD2,894,000USD2,713,000USD2,269,000USD
    Net Working Capital570,234,000USD265,857,000USD276,122,000USD255,997,000USD189,887,000USD189,944,000USD169,666,000USD177,573,000USD
    Unclassified Non Current Assets27,381,000USD22,887,000USD27,862,000USD——-37,338,000USD——
    Unclassified Current Liabilities-32,435,000USD11,309,000USD2,799,000USD8,860,000USD——-3,170,000USD-1,902,000USD
    Unclassified Non Current Liabilities63,276,000USD61,757,000USD62,330,000USD-22,982,000USD-47,593,000USD-40,504,000USD-53,431,000USD-37,007,000USD
    Unclassified Equity148,201,000USD-339,642,000USD-353,676,000USD-368,701,000USD-370,088,000USD-364,864,000USD-374,108,000USD-377,838,000USD
    Current Deferred Revenue—5,715,000USD5,553,000USD8,128,000USD6,995,000USD6,173,000USD3,219,000USD4,165,000USD
    Deferred Long Term Liab———17,194,000USD33,738,000USD24,134,000USD26,676,000USD22,632,000USD
    Other Liab———22,982,000USD47,593,000USD40,504,000USD53,431,000USD37,007,000USD
    Other Assets———19,527,000USD17,792,000USD47,829,000USD11,603,000USD11,761,000USD
    Net Tangible Assets———-77,077,000USD-179,198,000USD42,308,000USD-23,713,000USD7,673,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-07-03 · USD
    Depreciation28,808,000USD
    Stock Based Compensation19,632,000USD
    Deferred Income Tax-5,472,000USD
    Other Non Cash Items-2,283,000USD
    Change To Account Receivables4,246,000USD
    Change To Inventory-7,437,000USD
    Change In Working Capital-3,191,000USD
    Operating Cash Flow116,540,000USD
    Capital Expenditures-11,605,000USD
    Unclassified Investing Cash Flow345,000USD
    Investing Cash Flow-11,260,000USD
    Net Debt Issuance-19,154,000USD
    Net Common Stock Issuance-31,040,000USD
    Other Financing Activities-215,000USD
    Unclassified Financing Cash Flow280,885,000USD
    Financing Cash Flow230,476,000USD
    Effect Of Forex Changes On Cash2,023,000USD
    Change In Cash337,779,000USD
    End Cash Flow718,650,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income21,099,000USD17,471,000USD10,653,000USD4,497,000USD21,208,000USD16,464,000USD19,192,000USD13,755,000USD
    Depreciation14,160,000USD17,077,000USD15,711,000USD15,581,000USD13,563,000USD14,363,000USD14,155,000USD14,116,000USD
    Stock Based Compensation9,796,000USD8,242,000USD6,698,000USD7,498,000USD7,100,000USD4,635,000USD6,364,000USD6,231,000USD
    Other Non Cash Items10,004,000USD1,857,662USD1,706,000USD1,895,000USD-3,217,000USD1,171,000USD1,993,000USD4,869,000USD
    Change To Account Receivables9,703,000USD-14,704,479USD-10,175,000USD9,937,000USD-12,188,000USD9,894,000USD-17,310,000USD5,385,000USD
    Change To Inventory-6,827,000USD-8,427,827USD-13,055,000USD-14,196,000USD-61,000USD4,365,000USD7,002,000USD-2,805,000USD
    Change In Working Capital7,927,000USD-33,433,662USD-25,003,000USD-11,618,000USD-4,577,000USD28,930,000USD-14,481,000USD6,124,000USD
    Total Cash From Operating Activities50,313,000USD8,805,000USD8,495,000USD15,072,000USD31,684,000USD61,562,000USD23,026,000USD41,095,000USD
    Capital Expenditures-4,138,000USD-3,672,000USD-4,283,000USD-3,388,000USD-4,284,000USD-2,249,000USD-3,561,000USD-4,937,000USD
    Free Cash Flow46,175,000USD5,133,000USD4,211,999USD11,684,000USD27,400,000USD59,313,000USD19,465,000USD36,158,000USD
    Total Cashflows From Investing Activities-3,793,000USD-3,613,000USD-5,401,000USD-66,561,000USD1,253,000USD-2,076,000USD-3,561,000USD-4,937,000USD
    Net Borrowings-8,800,000USD-306,520,000USD-8,188,000USD61,507,000USD-29,719,000USD-35,083,000USD-28,639,000USD—
    Total Cash From Financing Activities-38,829,000USD287,649,000USD-23,420,000USD54,832,000USD-42,731,000USD-35,616,000USD-28,881,000USD-32,023,000USD
    Sale Purchase Of Stock-18,638,000USD-18,824,105USD-14,589,000USD-112,578USD-6,157,000USD—8,861,000USD-476,000USD
    Change In Cash7,928,000USD291,650,000USD-20,691,000USD3,867,000USD-7,944,000USD21,299,000USD-5,778,000USD4,948,000USD
    Begin Period Cash Flow380,871,000USD89,221,000USD109,912,000USD106,045,000USD113,989,000USD92,690,000USD98,468,000USD93,520,000USD
    End Period Cash Flow388,799,000USD380,871,000USD89,221,000USD109,912,000USD106,045,000USD113,989,000USD92,690,000USD98,468,000USD
    Other Cashflows From Investing Activities345,000USD59,000USD——5,537,000USD173,000USD-585,000USD-80,336USD
    Other Cashflows From Financing Activities-11,391,000USD-895,560USD-643,000USD-3,690,653USD-6,855,000USD-533,000USD-242,000USD-655,000USD
    Unclassified Operating Cash Flow-12,673,000USD-2,409,000USD-1,270,000USD-2,781,000USD-2,393,000USD-4,001,000USD-4,197,000USD-4,000,000USD
    Unclassified Financing Cash Flow—613,888,665USD—-2,871,769USD——-8,861,000USD-30,892,000USD
    Investments——-5,401,000USD-66,561,000USD1,253,000USD-2,076,000USD-3,561,000USD-4,937,000USD
    Unclassified Investing Cash Flow——4,283,000USD3,388,000USD-1,253,000USD2,076,000USD4,146,000USD5,017,336USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income53,829,000USD64,087,000USD72,878,000USD74,051,000USD50,331,000USD44,521,000USD40,773,000USD50,890,000USD
    Depreciation61,932,000USD55,563,000USD46,612,000USD53,158,000USD43,394,000USD38,293,000USD38,280,000USD37,052,000USD
    Stock Based Compensation29,538,000USD23,307,000USD25,588,000USD23,108,000USD25,606,000USD23,119,000USD9,340,000USD7,714,000USD
    Other Non Cash Items2,743,000USD12,546,000USD11,051,000USD3,853,000USD6,248,000USD-1,120,000USD6,628,000USD2,999,000USD
    Change To Account Receivables-27,272,000USD-6,193,000USD-127,000USD-23,246,000USD-25,355,000USD18,026,000USD-3,600,000USD-1,156,000USD
    Change To Inventory-36,101,000USD4,781,000USD11,366,000USD-48,547,000USD-19,078,000USD22,102,000USD-7,397,000USD-15,603,000USD
    Change In Working Capital-75,133,000USD18,918,000USD-21,328,000USD-44,737,000USD-27,009,000USD39,539,000USD-27,441,000USD-2,932,000USD
    Total Cash From Operating Activities64,056,000USD158,512,000USD120,075,000USD90,779,000USD94,625,000USD140,239,000USD63,248,000USD89,647,000USD
    Capital Expenditures-15,627,000USD-17,162,000USD-19,961,000USD-19,643,000USD-22,176,000USD-10,524,000USD-10,743,000USD-14,658,000USD
    Free Cash Flow48,429,000USD141,350,000USD100,114,000USD71,136,000USD72,449,000USD129,715,000USD52,505,000USD74,989,000USD
    Total Cashflows From Investing Activities-74,322,000USD-208,189,000USD-19,892,000USD-42,541,000USD-306,704,000USD-13,156,000USD-63,844,000USD-45,590,000USD
    Net Borrowings-282,920,000USD66,934,000USD-86,552,000USD8,420,000USD247,619,000USD-37,005,000USD13,443,000USD-19,395,000USD
    Total Cash From Financing Activities276,330,000USD56,943,000USD-97,853,000USD-60,154,000USD204,753,000USD-84,357,000USD-3,935,000USD-60,164,000USD
    Sale Purchase Of Stock-39,278,000USD-9,713,000USD-10,563,000USD-10,000,000USD-30,830,000USD-5,500,000USD-10,000,000USD-5,850,000USD
    Issuance Of Capital Stock614,390,000USD0USD0USD—————
    Change In Cash266,882,000USD8,938,000USD4,946,000USD-17,288,000USD-7,661,000USD46,110,000USD-3,099,000USD-18,014,000USD
    Begin Period Cash Flow113,989,000USD105,051,000USD100,105,000USD117,393,000USD125,054,000USD78,944,000USD82,043,000USD100,057,000USD
    End Period Cash Flow380,871,000USD113,989,000USD105,051,000USD100,105,000USD117,393,000USD125,054,000USD78,944,000USD82,043,000USD
    Other Cashflows From Investing Activities5,596,000USD173,000USD69,000USD-1,333,000USD200,000USD-2,632,000USD42,000USD-1,332,000USD
    Other Cashflows From Financing Activities-11,147,000USD-9,991,000USD-738,000USD-58,574,000USD-34,123,000USD-43,466,000USD-10,033,000USD-34,919,000USD
    Unclassified Operating Cash Flow-8,853,000USD-15,909,000USD-14,726,000USD-18,654,000USD-3,945,000USD-4,113,000USD-4,332,000USD-6,076,000USD
    Unclassified Investing Cash Flow-64,291,000USD16,989,000USD19,892,000USD20,976,000USD21,976,000USD13,156,000USD10,701,000USD15,990,000USD
    Unclassified Financing Cash Flow609,675,000USD9,713,000USD——22,087,000USD1,614,000USD2,655,000USD—
    Investments—-208,189,000USD-19,892,000USD-42,541,000USD-306,704,000USD-13,156,000USD-63,844,000USD-45,590,000USD
    Change To Liabilities———30,822,000USD24,376,000USD-8,469,000USD-19,766,000USD11,238,000USD
    Cash And Cash Equivalents Changes———-11,916,000USD-7,326,000USD42,726,000USD-3,099,000USD-18,014,000USD
    Exchange Rate Changes——————1,432,000USD-1,907,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-07-03GeographyChina25,456,000USDDisclosure
    Q2 2026Quarterly · 2026-07-03GeographyGermany33,310,000USDDisclosure
    Q2 2026Quarterly · 2026-07-03GeographyOther Countries9,060,000USDDisclosure
    Q2 2026Quarterly · 2026-07-03GeographyRest of Asia Pacific28,468,000USDDisclosure
    Q2 2026Quarterly · 2026-07-03GeographyRest Of Europe38,078,000USDDisclosure
    Q2 2026Quarterly · 2026-07-03GeographyUnited States131,435,000USDDisclosure
    Q2 2026Quarterly · 2026-07-03SegmentAutomation Enabling Technologies — Precision Manufacturing47,845,000USDDisclosure
    Q2 2026Quarterly · 2026-07-03SegmentMedical Solutions — Advanced Surgery67,515,000USDDisclosure
    Q2 2026Quarterly · 2026-07-03SegmentMedical Solutions — Precision Medicine62,077,000USDDisclosure
    Q2 2026Quarterly · 2026-07-03SegmentRobotics And Automation88,370,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyChina23,549,000USD0001193125-26-217064
    Q1 2026Quarterly · 2026-03-31GeographyGermany36,294,000USD0001193125-26-217064
    Q1 2026Quarterly · 2026-03-31GeographyOther Countries6,221,000USD0001193125-26-217064
    Q1 2026Quarterly · 2026-03-31GeographyRest of Asia Pacific27,389,000USD0001193125-26-217064
    Q1 2026Quarterly · 2026-03-31GeographyRest Of Europe42,240,000USD0001193125-26-217064
    Q1 2026Quarterly · 2026-03-31GeographyUnited States122,014,000USD0001193125-26-217064
    Q1 2026Quarterly · 2026-03-31SegmentAutomation Enabling Technologies — Precision Manufacturing47,074,000USD0001193125-26-217064
    Q1 2026Quarterly · 2026-03-31SegmentMedical Solutions — Advanced Surgery62,531,000USD0001193125-26-217064
    Q1 2026Quarterly · 2026-03-31SegmentMedical Solutions — Precision Medicine63,932,000USD0001193125-26-217064
    Q1 2026Quarterly · 2026-03-31SegmentRobotics And Automation84,170,000USD0001193125-26-217064
    Q4 2025Quarterly · 2025-12-31GeographyChina25,697,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyGermany31,815,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyOther Countries5,344,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyRest of Asia Pacific24,556,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyRest Of Europe34,117,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States136,820,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyChina93,201,000USD0001193125-26-064230
    FY 2025Yearly · 2025-12-31GeographyGermany114,647,000USD0001193125-26-064230
    FY 2025Yearly · 2025-12-31GeographyOther Countries19,305,000USD0001193125-26-064230
    FY 2025Yearly · 2025-12-31GeographyRest of Asia Pacific97,034,000USD0001193125-26-064230
    FY 2025Yearly · 2025-12-31GeographyRest Of Europe137,406,000USD0001193125-26-064230
    FY 2025Yearly · 2025-12-31GeographyUnited States519,007,000USD0001193125-26-064230
    FY 2025Yearly · 2025-12-31SegmentAutomation Enabling Technologies — Precision Manufacturing182,258,000USD0001193125-26-064230
    FY 2025Yearly · 2025-12-31SegmentMedical Solutions — Advanced Surgery242,444,000USD0001193125-26-064230
    FY 2025Yearly · 2025-12-31SegmentMedical Solutions — Precision Medicine237,321,000USD0001193125-26-064230
    FY 2025Yearly · 2025-12-31SegmentRobotics And Automation318,577,000USD0001193125-26-064230
    Q3 2025Quarterly · 2025-09-30GeographyChina24,293,000USD0001193125-25-262774
    Q3 2025Quarterly · 2025-09-30GeographyGermany27,097,000USD0001193125-25-262774
    Q3 2025Quarterly · 2025-09-30GeographyOther Countries4,930,000USD0001193125-25-262774
    Q3 2025Quarterly · 2025-09-30GeographyRest of Asia Pacific24,432,000USD0001193125-25-262774
    Q3 2025Quarterly · 2025-09-30GeographyRest Of Europe36,661,000USD0001193125-25-262774
    Q3 2025Quarterly · 2025-09-30GeographyUnited States130,423,000USD0001193125-25-262774
    Q3 2025Quarterly · 2025-09-30SegmentAutomation Enabling Technologies125,316,000USD0001193125-25-262774
    Q3 2025Quarterly · 2025-09-30SegmentMedical Solutions122,520,000USD0001193125-25-262774
    Q2 2025Quarterly · 2025-06-30GeographyChina21,777,000USD0000950170-25-102475
    Q2 2025Quarterly · 2025-06-30GeographyGermany27,258,000USD0000950170-25-102475
    Q2 2025Quarterly · 2025-06-30GeographyOther Countries4,382,000USD0000950170-25-102475
    Q2 2025Quarterly · 2025-06-30GeographyRest of Asia Pacific24,667,000USD0000950170-25-102475
    Q2 2025Quarterly · 2025-06-30GeographyRest Of Europe34,847,000USD0000950170-25-102475
    Q2 2025Quarterly · 2025-06-30GeographyUnited States128,118,000USD0000950170-25-102475
    Q2 2025Quarterly · 2025-06-30SegmentAutomation Enabling Technologies — Precision Manufacturing43,837,000USD0000950170-25-102475
    Q2 2025Quarterly · 2025-06-30SegmentMedical Solutions — Advanced Surgery60,216,000USD0000950170-25-102475
    Q2 2025Quarterly · 2025-06-30SegmentMedical Solutions — Precision Medicine59,161,000USD0000950170-25-102475
    Q2 2025Quarterly · 2025-06-30SegmentRobotics And Automation77,835,000USD0000950170-25-102475
    Q1 2025Quarterly · 2025-03-31GeographyChina21,434,000USD0001193125-26-217064
    Q1 2025Quarterly · 2025-03-31GeographyGermany28,477,000USD0001193125-26-217064
    Q1 2025Quarterly · 2025-03-31GeographyOther Countries4,649,000USD0001193125-26-217064
    Q1 2025Quarterly · 2025-03-31GeographyRest of Asia Pacific23,379,000USD0001193125-26-217064
    Q1 2025Quarterly · 2025-03-31GeographyRest Of Europe31,781,000USD0001193125-26-217064
    Q1 2025Quarterly · 2025-03-31GeographyUnited States123,646,000USD0001193125-26-217064
    Q1 2025Quarterly · 2025-03-31SegmentAutomation Enabling Technologies — Precision Manufacturing44,579,000USD0001193125-26-217064
    Q1 2025Quarterly · 2025-03-31SegmentMedical Solutions — Advanced Surgery56,188,000USD0001193125-26-217064
    Q1 2025Quarterly · 2025-03-31SegmentMedical Solutions — Precision Medicine54,011,000USD0001193125-26-217064
    Q1 2025Quarterly · 2025-03-31SegmentRobotics And Automation78,588,000USD0001193125-26-217064
    Q4 2024Quarterly · 2024-12-31GeographyChina23,854,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyGermany24,585,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyOther Countries5,202,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyRest of Asia Pacific27,317,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyRest Of Europe34,788,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States122,314,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyChina84,562,000USD0001193125-26-064230
    FY 2024Yearly · 2024-12-31GeographyGermany123,244,000USD0001193125-26-064230
    FY 2024Yearly · 2024-12-31GeographyOther Countries18,400,000USD0001193125-26-064230
    FY 2024Yearly · 2024-12-31GeographyRest of Asia Pacific107,054,000USD0001193125-26-064230
    FY 2024Yearly · 2024-12-31GeographyRest Of Europe128,871,000USD0001193125-26-064230
    FY 2024Yearly · 2024-12-31GeographyUnited States487,114,000USD0001193125-26-064230
    FY 2024Yearly · 2024-12-31SegmentAutomation Enabling Technologies — Precision Manufacturing202,303,000USD0001193125-26-064230
    FY 2024Yearly · 2024-12-31SegmentMedical Solutions — Advanced Surgery208,753,000USD0001193125-26-064230
    FY 2024Yearly · 2024-12-31SegmentMedical Solutions — Precision Medicine249,872,000USD0001193125-26-064230
    FY 2024Yearly · 2024-12-31SegmentRobotics And Automation288,317,000USD0001193125-26-064230
    Q3 2024Quarterly · 2024-09-30GeographyChina24,623,000USD0001193125-25-262774
    Q3 2024Quarterly · 2024-09-30GeographyGermany33,559,000USD0001193125-25-262774
    Q3 2024Quarterly · 2024-09-30GeographyOther Countries4,164,000USD0001193125-25-262774
    Q3 2024Quarterly · 2024-09-30GeographyRest of Asia Pacific27,147,000USD0001193125-25-262774
    Q3 2024Quarterly · 2024-09-30GeographyRest Of Europe30,584,000USD0001193125-25-262774
    Q3 2024Quarterly · 2024-09-30GeographyUnited States124,328,000USD0001193125-25-262774
    Q3 2024Quarterly · 2024-09-30SegmentMedical Solutions103,783,000USD0000950170-24-121113
    Q3 2024Quarterly · 2024-09-30SegmentPrecision Medicine And Manufacturing60,595,000USD0000950170-24-121113
    Q3 2024Quarterly · 2024-09-30SegmentRobotics And Automation80,027,000USD0000950170-24-121113
    Q2 2024Quarterly · 2024-06-30SegmentAutomation Enabling Technologies — Precision Manufacturing49,343,000USD0000950170-25-102475
    Q2 2024Quarterly · 2024-06-30SegmentMedical Solutions — Advanced Surgery51,425,000USD0000950170-25-102475
    Q2 2024Quarterly · 2024-06-30SegmentMedical Solutions — Precision Medicine67,710,000USD0000950170-25-102475
    Q2 2024Quarterly · 2024-06-30SegmentRobotics And Automation67,386,000USD0000950170-25-102475
    Q1 2024Quarterly · 2024-03-31SegmentAutomation Enabling Technologies — Precision Manufacturing54,159,000USD0000950170-25-064018
    Q1 2024Quarterly · 2024-03-31SegmentMedical Solutions — Advanced Surgery48,926,000USD0000950170-25-064018
    Q1 2024Quarterly · 2024-03-31SegmentMedical Solutions — Precision Medicine64,601,000USD0000950170-25-064018
    Q1 2024Quarterly · 2024-03-31SegmentRobotics And Automation63,230,000USD0000950170-25-064018
    FY 2023Yearly · 2023-12-31GeographyChina73,444,000USD0001193125-26-064230
    FY 2023Yearly · 2023-12-31GeographyGermany128,229,000USD0001193125-26-064230
    FY 2023Yearly · 2023-12-31GeographyOther Countries19,347,000USD0001193125-26-064230

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.